Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2026-01-07 @ 2:50 AM
Study NCT ID:
NCT06877533
Status:
TERMINATED
Last Update Posted:
2025-08-12
First Post:
2025-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With Advanced Solid Tumors
Sponsor:
iTeos Belgium SA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-04-07
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-07-10
Completion Date Type:
ACTUAL
First Submit Date:
2025-03-10
First Submit QC Date:
None
Study First Post Date:
2025-03-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-07
Last Update Post Date:
2025-08-12
Last Update Post Date Type:
ACTUAL